MedPlus Health Services share price rose nearly 2 percent in the early trade on July 16 despite the company subsidiary received suspension order for its three stores.
The company received an order from Assistant Director, Drugs Control Administration, Bangalore Circle-02 Karnataka for suspension of drug license for three days of a store situated at Basavangudi Rathnavilas road, Karnataka.
The said suspension order will see a potential revenue loss of approximately Rs 1.87 lacs.
The company also received suspension of drug license for seven days of a store situated at west Marredpally Secundrabad and for three days of store situated at Satyanarayana colony Shameerpet, Telangana, from Assistant Director, Drugs Control Administration, Telangana.
The said suspensions may cause a potential revenue loss of approximately Rs 0.80 lakhs and Rs 1.21 lakhs, respectively
Catch all the market action on our live blog
The meeting of the board of directors of the company is scheduled to be held on August 02, 2025 to consider and approve the un-audited standalone and consolidated financial results of the company for the quarter ended June 30, 2025.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
